ArticlePLoS computational biology2026
PepLM-GNN: A graph neural network framework leveraging pre-trained language models for peptide-protein binding prediction.
Article in PLoS computational biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
motivationThe precise prediction of peptide-protein interaction (PepPI) is a core support for promoting breakthroughs in peptide drug research, as well as understanding the regulatory mechanisms of biomolecules. Researchers have developed several computational methods to predict PepPI. However, existing computational methods also have significant limitations. At the level of data feature characterisation, the problem of PepPI does not conform to the Euclidean axioms, making it difficult for conventional prediction methods to effectively measure the underlying correlations between peptides and proteins. At the level of model generalisation performance, existing approaches are often hampered by insufficient generalisation ability, as manifested by their markedly degraded performance in cold start scenarios involving novel peptides, novel proteins, and novel binding pairs.
resultsIn this study, we propose a computing framework, PepLM-GNN, that integrates a pre-trained language ProtT5 model with a hybrid graph network for accurate identification of PepPI. This model constructs a graph by using ProtT5-extracted semantic context features of peptides and proteins to form heterogeneous nodes, with edges connecting interacting peptide-protein pairs. The hybrid graph network Graph Convolutional Networks (GCN) provides the comprehensive information of the peptide and protein sequences, while employing the Graph Isomorphism Network (GIN) to capture the global interactions between them. Specifically, the GCN aggregates both the semantic context information of node sequences and local neighbourhood information, effectively representing non-Euclidean data. To capture the global associations, we adopt a GIN strategy to optimize the cross-node feature interaction and transfer process, thereby enhancing the generalisation performance of addressing the cold start scenario. Compared with the existing advanced methods, PepLM-GNN demonstrated highly accurate performance and robustness in predicting the PepPI. We further demonstrated the capabilities of PepLM-GNN in virtual peptide drug screening, which is expected to facilitate the discovery of peptide drugs and the elucidation of protein functions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.